Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
contraceptive
Pharma
Contraline gins up $92.5M in male birth control development push
Contraline is developing what could be a first-in-class male birth control that has garnered enthusiasm from a host of big-name investors.
Fraiser Kansteiner
Jun 2, 2026 8:00am
Organon hunts for new CEO after probe exposes sales misconduct
Oct 27, 2025 10:00am
FDA accuses Mayne of giving misleading impression of drug safety
May 13, 2025 9:30am
Lupin recalls birth control pills deemed possibly ineffective
Aug 1, 2023 8:21am
Perrigo snags historic OTC nod for birth control tablet Opill
Jul 13, 2023 9:45am
Perrigo's OTC birth control pill aces FDA expert meeting
May 10, 2023 4:40pm
